A
banner
A

   

Optimizing Biologics Formulations

Quantifying Trace Subvisible Protein Aggregates Using a Protein Aggregation Assay and Standards

Aggregation represents one of the most significant obstacles to the development of protein-based pharmaceuticals. During drug formulation, protein aggregation can impact product quality in terms of biological activity and immunogenicity.

Protein aggregation can occur at all stages in the manufacturing process including cell culture, purification, formulation, storage, shipping, and handling. The pharmaceutical industry requires improved methods to detect, monitor, and quantify factors governing aggregation during manufacturing.

For more information. please visit- http://www.genengnews.com/gen-articles/optimizing-biologics-formulations/4076/


Note:
This website, service and content provided herein is for general information and is on "as is" and "as available" basis with no warranties of any kind. We expressly disclaim any and all warranties, expressed or implied, including without limitation, regarding the security, reliability, accuracy and performance of the services or information provided on this site. The user assumes all responsibility and risk for use of the site and services and their reliance on any materials provided on or through this website.